Pharmaceutical companies have encountered a variety of unprecedented
challenges, since the beginning of the COVID-19 epidemic. It led to a record-high
demand for vaccines, the suspension of numerous clinical trials, and a global
shortage of medicines. It is a fact that the devastating effects of the COVID-19
epidemic led to inefficiencies in the healthcare system. In that instance, the
European countries were not an exception, one side the pharmaceutical sector is a
highly capital and knowledge-intensive industry in the world, which spends
around 15 % of the total revenue on research and development (R&D). The
study’s research problem is that pharmaceutical companies invest large sums of
money in their businesses, but they face numerous contemporary challenges and
insufficient studies on factors that influence business performance. The research
aims to identify the key factors influencing European pharmaceutical firms’
business performance by highlighting their current challenges and prospects. To
conduct this study, we used several techniques to find out the core variables of
pharmaceutical companies’ success, basically under three steps.
| ISBN: | 978-80-7678-335-5 |
|---|
| EAN: | 9788076783355 |
|---|
| Počet stran |
47 stran |
| Datum vydání |
10. 06. 2025 |
| Pořadí vydání |
První |
| Jazyk |
anglický |
| Vazba |
e-kniha - pdf |
| Autor: |
Arif Ibne Asad |
| Nakladatelství |
Univerzita Tomáše Bati ve Zlíně |
| Tématická skupina |
999 - nezařazeno |
| Neprodejná publikace. Publikaci je možné poptávat zde: Volně dostupné na http://hdl.handle.net/10563/56855 |
|---|
Svaz českých knihkupců a nakladatelů